Key takeaway
In 1521 Spanish adults aged 55-75 with overweight or obesity and metabolic syndrome, an energy-reduced Mediterranean diet plus physical activity lowered total fat by 0.38 percentage points more than usual care at 3 years (95% CI -0.64 to -0.12). The differences shrank from year 1 to year 3, and this is an interim subgroup analysis with measures from DXA-equipped centres only.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Diet and exercise programs are usually judged by body weight, but weight does not show whether fat or muscle was lost. The authors asked whether a lifestyle weight-loss program changed total fat, visceral fat and lean mass over 3 years.
Who and how
Interim subgroup analysis of the ongoing PREDIMED-Plus randomized trial in 23 Spanish research centres, in adults aged 55-75 with body mass index between 27 and 40 and metabolic syndrome. Of 6874 participants, 1521 from centres with dual energy x-ray absorptiometry (DXA) had body composition measured at 3 time points. The intervention (n = 760) was an energy-reduced Mediterranean diet plus increased physical activity; the control group (n = 761) got usual care with advice on an ad libitum Mediterranean diet and no activity promotion. Outcomes were 3-year changes in total fat and lean mass (as percentages of body mass) and visceral fat (in grams), using linear mixed-effects models, plus improvements of 5% or more using logistic regression. Main analyses used completers, with multiple imputation as sensitivity analysis. Mean age was 65.3 years (SD 5.0) and 52.1% were men.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Total fat percentage fell more in the intervention group: between-group difference -0.94% at 1 year (95% CI -1.19 to -0.69) and -0.38% at 3 years (95% CI -0.64 to -0.12).
- 2Visceral fat fell more: -126 g at 1 year (95% CI -179 to -73.3) and -70.4 g at 3 years (95% CI -126 to -15.2).
- 3Lean mass percentage rose more: 0.88% at 1 year (95% CI 0.63% to 1.12%) and 0.34% at 3 years (95% CI 0.09% to 0.60%).
- 4More people in the intervention group improved fat or lean mass by 5% or more: absolute risk reduction at 1 year was 13% for total fat, 11% for lean mass and 14% for visceral fat; at 3 years, 6%, 6% and 8%. The number needed to treat was between 12 and 17.
Limits & uncertainty
- 1Interim analysis of a trial designed to test cardiovascular outcomes after 8 years, so body composition here is an intermediate outcome and cardiovascular benefit is not yet shown.
- 2Only 1521 of 6874 participants (those at centres with DXA) were included, so this is a subgroup.
- 3Primary analyses were done in completers, which can favour participants who stuck with the program, and the abstract does not report dropout or the multiple-imputation results.
- 4The benefit narrowed between 1 and 3 years (for example total fat -0.94% to -0.38%), and the multifactorial program mixes diet and activity, so their separate effects cannot be told apart.
What to take from it
In older adults with excess weight and metabolic syndrome, a structured program of calorie-reduced Mediterranean eating plus more activity improved body composition, with modest differences versus usual care that shrank over 3 years. It does not tell you how much of this came from diet versus exercise or whether it prevents heart disease. Plans should be set with your clinician.
Reading your own data
Weight, waist and, if your scale offers it, body fat percentage are the closest personal measures, but home bioimpedance scales are less accurate than DXA. Use the same scale, time of day and hydration, and follow monthly trends, not daily jumps.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Importance
Strategies targeting body composition may help prevent chronic diseases in persons with excess weight, but randomized clinical trials evaluating lifestyle interventions have rarely reported effects on directly quantified body composition.
Objective
To evaluate the effects of a lifestyle weight-loss intervention on changes in overall and regional body composition.
Design, setting, and participants
The ongoing Prevención con Dieta Mediterránea-Plus (PREDIMED-Plus) randomized clinical trial is designed to test the effect of the intervention on cardiovascular disease prevention after 8 years of follow-up. The trial is being conducted in 23 Spanish research centers and includes men and women (age 55-75 years) with body mass index between 27 and 40 and metabolic syndrome. The trial reported herein is an interim subgroup analysis of the intermediate outcome body composition after 3-year follow-up, and data analysis was conducted from February 1 to November 30, 2022. Of 6874 total PREDIMED-Plus participants, a subsample of 1521 individuals, coming from centers with access to a dual energy x-ray absorptiometry device, underwent body composition measurements at 3 time points.
Intervention
Participants were randomly allocated to a multifactorial intervention based on an energy-reduced Mediterranean diet (MedDiet) and increased physical activity (PA) or to a control group based on usual care, with advice to follow an ad libitum MedDiet, but no physical activity promotion.
Main outcomes and measures
The outcomes (continuous) were 3-year changes in total fat and lean mass (expressed as percentages of body mass) and visceral fat (in grams), tested using multivariable linear mixed-effects models. Clinical relevance of changes in body components (dichotomous) was assessed based on 5% or more improvements in baseline values, using logistic regression. Main analyses were performed in the evaluable population (completers only) and in sensitivity analyses, multiple imputation was performed to include data of participants lost to follow-up (intention-to-treat analyses).
Results
A total of 1521 individuals were included (mean [SD] age, 65.3 [5.0] years; 52.1% men). In comparison with the control group (n=761), participants in the intervention arm (n=760) showed greater reductions in the percentage of total fat (between group differences after 1-year, -0.94% [95% CI, -1.19 to -0.69]; 3 years, -0.38% [95% CI, -0.64 to -0.12] and visceral fat storage after 1 year, -126 g [95% CI, -179 to -73.3 g]; 3 years, -70.4 g [95% CI, -126 to -15.2 g] and greater increases in the percentage of total lean mass at 1 year, 0.88% [95% CI, 0.63%-1.12%]; 3-years 0.34% [95% CI, 0.09%-0.60%]). The intervention group was more likely to show improvements of 5% or more in baseline body components (absolute risk reduction after 1 year, 13% for total fat mass, 11% for total lean mass, and 14% for visceral fat mass; after 3-years: 6% for total fat mass, 6% for total lean mass, and 8% for visceral fat mass). The number of participants needed to treat was between 12 and 17 to attain at least 1 individual with possibly clinically meaningful improvements in body composition.
Conclusions and relevance
The findings of this trial suggest a weight-loss lifestyle intervention based on an energy-reduced MedDiet and physical activity significantly reduced total and visceral fat and attenuated age-related losses of lean mass in older adults with overweight or obesity and metabolic syndrome. Continued follow-up is warranted to confirm the long-term consequences of these changes on cardiovascular clinical end points.
Trial registration
isrctn.org Identifier: ISRCTN89898870.
Sources & attribution
An Energy-Reduced Mediterranean Diet, Physical Activity, and Body Composition: An Interim Subgroup Analysis of the PREDIMED-Plus Randomized Clinical Trial.
Konieczna J, Ruiz-Canela M, Galmes-Panades AM, Abete I, Babio N, Fiol M, Martín-Sánchez V, Estruch R, Vidal J, Buil-Cosiales P, García-Gavilán JF, Moñino M, Marcos-Delgado A, Casas R, Olbeyra R, Fitó M, Hu FB, Martínez-Gonzalez MÁ, Martínez JA, Romaguera D, Salas-Salvadó J.
JAMA network open · 2023-10-02
DOI: 10.1001/jamanetworkopen.2023.37994 ↗PubMed · 37851444 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

